Publications - Michele Y . Halyard, M.D.

Back to Research Profile

1. Halyard MY, Pisansky TM, Dueck AC, Suman VJ, Pierce LJ, Solin LJ, Marks LB, Davidson N, Martino S, Kaufman P, Kutteh L, Dakhil S, Perez EA. Reply to N. Magne et al. J Clin Oncol 2009 Nov 02. [Epub ahead of print]
   View PubMed
2. Pockaj BA, Degnim AC, Boughey JC, Gray RJ, McLaughlin SA, Dueck AC, Perez EA, Halyard MY, Frost MH, Cheville AL, Sloan JA. Quality of life after breast cancer surgery: What have we learned and where should we go next? J Surg Oncol 2009 Jun 1; 99(7):447-55.
   View PubMed
3. Halyard MY, Pisansky TM, Dueck AC, Suman V, Pierce L, Solin L, Marks L, Davidson N, Martino S, Kaufman P, Kutteh L, Dakhil SR, Perez EA. Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol 2009 Jun 1; 27(16):2638-44. Epub 2009 Apr 06.
   View PubMed
4. Sprangers MA, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AP, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, Van Noorden CJ, Patrick DL, Pedersen The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet 2009 Jun; 12(3):301-11.
   View PubMed
5. Sprangers MA, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AP, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, Van Noorden CJ, Patrick DL, Pedersen The establishment of the GENEQOL Consortium to Investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet 2009 Jun; 12(3):301-11.
   View PubMed
6. Tondato F, Ng DW, Srivathsan K, Altemose GT, Halyard MY, Scott LR. Radiotherapy-induced pacemaker and implantable cardioverter defibrillator malfunction. Expert Rev Med Devices 2009 May; 6(3):243-9.
   View PubMed
7. Martenson JA, Halyard MY, Sloan JA, Proulx GM, Miller RC, Deming RL, Dick SJ, Johnson HA, Tai TH, Zhu AW, Keit J, Stien KJ, Atherton PJ. Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA. J Clin Oncol 2008 Nov 10; 26(32):5248-53. Epub 2008 Sep 02.
   View PubMed
8. Carpenter S, Fraser J, Fleming M, Gray R, Halyard M, Pockaj B. Optimal treatment of multiple ipsilateral primary breast cancers. Am J Surg 2008 Oct; 196(4):530-6.
   View PubMed
9. Halyard MY, Ferrans CE. Quality-of-Life assessment for routine oncology clinical practice. J Support Oncol 2008 May-Jun; 6(5):221-9, 233.
   View PubMed
10. Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE, Halyard MY, Revicki DA, Symonds T, Parada A, Alonso J. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res 2008 Mar; 17(2):179-93. Epub 2008 Jan 04.
    View PubMed
11. Sloan JA, Halyard MY, Frost MH, Dueck AC, Teschendorf B, Rothman ML, Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes. Value Health 2007 Nov-Dec; 10 Suppl 2:S59-63.
    View PubMed
12. Sloan JA, Halyard MY, Frost MH, Dueck AC, Teschendorf B, Rothman ML. The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes. Value Health 2007 Nov-Dec; 10(Suppl 2):S59-63.
    View PubMed
13. Guyatt GH, Ferrans CE, Halyard MY, Revicki DA, Symonds TL, Varricchio CG, Kotzeva A, Valderas JM, Alonso JL, Clinical Significance Consensus Meeting Group. Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. Mayo Clin Proc 2007 Oct; 82(10):1229-39.
    View PubMed
14. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2007 Jul 15; 68(4):1053-8.
    View PubMed
15. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2007 Jul 15; 68(4):1053-8. Epub 2007 Mar 29.
    View PubMed
16. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys 2007 Apr 1; 67(5):1318-22.
    View PubMed
17. Vora SA, Wong WW, Schild SE, Ezzell G, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low dose 3-dimensional conformal radiation therapy or high dose IMRT for localized prostate cancer. Int J Radiat Oncol Biol Phys (in press) 2007.
18. Halyard MY, Frost MH, Dueck A. Integrating QOL assessments for clinical and research purposes. Curr Probl Cancer 2006 Nov-Dec; 30(6):319-30.
    View PubMed
19. Halyard MY, Frost MH, Dueck A, Sloan JA. Is the use of QOL data really any different than other medical testing? Curr Probl Cancer 2006 Nov-Dec; 30(6):261-71.
    View PubMed
20. Sloan JA, Frost MH, Berzon R, Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D, Clinical Significance Consensus Meeting Group. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer 2006 Oct; 14(10):988-98.
    View PubMed
21. Sloan JA, Frost MH, Berzon R, Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D, Clinical Significance Consensus Meeting Group. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer 2006 Oct; 14(10):988-98. Epub 2006 Jun 23.
    View PubMed
22. Halyard M, Sloan J. Applying QOL Assessments: Are solutions for QOL different than other medical testing?. Curr Probl Cancer 2006.
23. Brown PD, Foote RL, McLaughlin MP, Halyard MY, Ballman KV, Collie AC, Miller RC, Flemming KD, Hallett JW. A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys 2005 Dec 1; 63(5):1361-7.
    View PubMed
24. Stearns L, Boortz-Marx R, Du Pen S, Friehs G, Gordon M, Halyard M, Herbst L, Kiser J. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. J Support Oncol 2005 Nov-Dec; 3(6):399-408.
    View PubMed
25. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer - Related lymphedema. Mayo Clin Proc 2005 Nov; 80(11):1480-4.
    View PubMed
26. Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH. The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2005 Aug 1; 62(5):1432-7.
27. Wong WW, Schild SE, Vora SA, Halyard MY. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004 Sep 1; 60(1):24-9.
    View PubMed
28. Halyard MY, McCombs KE, Wong WW, Buchel EW, Pockaj BA, Vora SA, Gray RJ, Schild SE. Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for breast cancer. Am J Clin Oncol 2004 Aug; 27(4):389-94.
    View PubMed
29. Gray RJ, Forstner-Barthell AW, Pockaj BA, Schild SE, Halyard MY. Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients, with previous implant breast augmentation. Am J Surg 2004 Aug; 188(2):122-5.
    View PubMed
30. Halyard MY, McElrath MF, Abbott DL, Bour TC, Anderson JA. Building values from the ground up: the opening of the Mayo Clinic Hospital: building a workforce that fosters the organizational culture. Group Pract J 2003; 52(9):9-11.
31. Schild SE, Wong WW, Vora SA, Halyard MY, Wheeler RH. Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002 Nov 1; 54(3):729-34.
    View PubMed
32. Wong WW, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic experience. J Surg Oncol 2002 May; 80(1):19-25.
    View PubMed
33. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S. Novotny PJ, Rumman TA. Phase III evaluation of fluoxetine for treatment of hot flashes J Clin Oncol 2002; 20(6):1578-83.
34. Schomberg PJ, Shanahan TG, Ingle JN, Donohue JH, Kuske RR, Sternfeld WC, Wold L, Cha SS, Petersen IA, Brindle JS, Halyard MY, Bollinger JW, Hawkins R, Pisansky TM. Accelerated hyperfractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage I or II breast cancer: pilot study. Radiology 1997 Feb; 202(2):565-9.
    View PubMed
35. Halyard MY, Camoriano JK, Culligan JA, Weiland LH, Allen MS, Pluth JR, Pairolero PC. Malignant fibrous histiocytoma of the lung. Report of four cases and review of the literature. Cancer 1996 Dec 15; 78(12):2492-7.
    View PubMed
36. Schild SE, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, Ferrigni RG. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol 1996 Nov; 156(5):1725-9.
    View PubMed
37. Halyard MY, Grado GL, Schomberg PJ, Weaver AL, Grant CS, Pisansky TM. Conservative therapy of breast cancer. The Mayo Clinic experience. Am J Clin Oncol 1996 Oct; 19(5):445-50.
    View PubMed
38. Halyard MY, Cornella JL, Grado GL, Rizzo NR. Prolonged amenorrhea associated with total nodal irradiation for Hodgkin's disease. J Natl Med Assoc 1996 Jun; 88(6):391-3.
    View PubMed
39. Schild SE, Wong WW, Grado GL, Halyard MY, Novicki DE, Swanson SK, Larson TR, Ferrigni RG. The results of radical retropubic prostatectomy and adjuvant therapy for pathologic stage c prostate cancer. Int J Radiat Oncol Biol Phys 1996 Feb 1; 34(3):535-41.
    View PubMed
40. Pisansky TM, Halyard MY, Weaver AL, Donohue JH, Grado GL, Grant CS, Hartmann LC, Ingle JN, Schomberg PJ, Wold LE. Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experience. Mayo Clin Proc 1994 Jun; 69(6):515-24.
    View PubMed
41. Schamadan JL, Covalciuc MA, Halyard MY, Trump DS, Whysong GL. Cancer in professional firefighters. Arizona Study Commission Report 1992 Feb.
42. Tuckson WB, Goldson AL, Ashayeri E, Halyard M, DeWitty RL, Leffall LD. Intraoperative radiotherapy for patients with carcinoma of the pancreas: the Howard University Hospital experience 1978-1986. Ann Surg 1988; 207:648-54.
    View PubMed
43. Ashayeri EA, Halyard MY, Goldson A, et al. The first simultaneous intraoperative hyperthermia and radiotherapy procedure: dog experiment and technique. J Nat Med Assoc 1987; 79:619-24.
44. Collier-Manning JD, Ashayeri EA, Goldson AL, Halyard MY, et al. The use of intraoperative radiotherapy and external beam therapy in the management of desmoid tumors. J Nat Med Assoc 1986; 78:893-5.
45. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of Phase III Double-Blind, Placebo-Controlled Trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys 2007 Apr 1; 67(5):1318-22.
    View PubMed